Delivery Order SPE2DB20D1004-SPE2DB24FG3D3
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,724.00 and an Ultimate Completion Date of May 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 50 mg capsules in 100-count packages to the U.S. Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024, with a completion date of August 26, 2024. The contract has a firm fixed price of $1,706.30 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,337.70 and is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the supply of Vyvanse 50 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $5,343.24 and has an ultimate completion date of August 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,024.00 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This federal contract award is for the delivery of Vyvanse 40 mg capsules (100 count) to the Defense Logistics Agency (DLA). The $1,337.70 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024, with a completion date of December 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
The federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a major defense agency of the U.S. government. The $3,488.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor. This contract is a child of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 40 mg capsules in quantities of 100 per bottle. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a firm-fixed-price delivery order with a ceiling value of $1,598.89 and an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of Vyvanse 10 mg capsules to the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense. The $1,318.93 contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, on a Firm Fixed Price basis. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. This...